Conjunctival MALT lymphoma: utility of FDG PET/CT for diagnosis, staging, and evaluation of treatment response.


Autoria(s): Sallak A.; Besson F.L.; Pomoni A.; Christinat A.; Adler M.; Aegerter J.P.; Nguyen C.; de Leval L.; Frossard V.; Prior J.O.
Data(s)

2014

Resumo

A 67-year-old woman was referred for staging of a mucosa-associated lymphoid tumor lymphoma involving the left conjunctiva. CT scan had shown paravertebral and pelvic masses, and a breast nodule. FDG PET/CT demonstrated moderately increased uptake in the left ocular conjunctiva and confirmed the paravertebral and pelvic masses and the breast nodule. Moreover, abnormal FDG uptake was shown in 2 breast nodules, the flank, the gluteus maximus, and the gastric cardia. The patient received 6 cycles of rituximab-bendamustine chemotherapy with a complete clinical and metabolic response at the 6-month follow-up PET/CT and remained relapse-free without visual acuity problem after a 36-month follow-up.

Identificador

https://serval.unil.ch/?id=serval:BIB_009F834B565E

isbn:1536-0229 (Electronic)

doi:10.1097/RLU.0000000000000356

isiid:000337304400031

pmid:24458180

http://my.unil.ch/serval/document/BIB_009F834B565E.pdf

http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_009F834B565E8

Idioma(s)

en

Direitos

info:eu-repo/semantics/openAccess

Fonte

Clinical Nuclear Medicine, vol. 39, no. 3, pp. 295-297

Tipo

info:eu-repo/semantics/article

article